Deciphering metabolic rewiring in breast cancer subtypes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2017-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.trsl.2017.07.004PMID 28774752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2019cited by this paper
• Understanding the Intersections between Metabolism and Cancer Biology.

  2017cited by this paper
• Glutaminolysis: A Hallmark of Cancer Metabolism.

  2017cited by this paper
• Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.

  2017cited by this paper
• Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells.

  2017cited by this paper
• Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

  2017cited by this paper
• Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes

  2017influential reference
• [18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition.

  2017cited by this paper
• NMR-based Stable Isotope Resolved Metabolomics in systems biochemistry.

  2017cited by this paper
• Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration

  2017cited by this paper
• Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

  2016cited by this paper
• A perspective on anti-EGFR therapies targeting triple-negative breast cancer.

  2016cited by this paper
• In vivo cancer metabolism is defined by the nutrient microenvironment

  2016cited by this paper
• Natural fatty acid synthase inhibitors as potent therapeutic agents for cancers: A review

  2016cited by this paper
• Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.

  2016cited by this paper
• Trends in Obesity Among Adults in the United States, 2005 to 2014.

  2016cited by this paper
• PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

  2016cited by this paper
• Cancer Metabolomics and the Human Metabolome Database

  2016cited by this paper
• Cystine addiction of triple negative breast cancer associated with EMT augmented death signaling

  2016cited by this paper
• Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib.

  2016cited by this paper
• Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.

  2016cited by this paper
• EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape.

  2016cited by this paper
• Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

  2016cited by this paper
• Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells

  2016cited by this paper
• Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine

  2016cited by this paper
• Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

  2016cited by this paper
• Pubertal and adult windows of susceptibility to a high animal fat diet in Trp53-null mammary tumorigenesis

  2016cited by this paper
• Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.

  2016cited by this paper
• Organ-Specific Cancer Metabolism and Its Potential for Therapy.

  2016cited by this paper
• The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

  2016cited by this paper
• mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer

  2016cited by this paper
• Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.

  2016cited by this paper
• Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics

  2016cited by this paper
• The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug

  2016cited by this paper
• Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis

  2016cited by this paper
• Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells

  2016cited by this paper
• Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis.

  2016cited by this paper
• Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes

  2016cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells*

  2016cited by this paper
• The importance of serine metabolism in cancer

  2016cited by this paper
• Obesity and Cancer: The Oil that Feeds the Flame.

  2016cited by this paper
• Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

  2016cited by this paper
• PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.

  2016influential reference
• Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database

  2016cited by this paper
• Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

  2016cited by this paper
• Fundamentals of cancer metabolism

  2016cited by this paper
• Cancer treatment and survivorship statistics, 2016

  2016cited by this paper
• Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer

  2016cited by this paper
• Forecasting individual breast cancer risk using plasma metabolomics and biocontours

  2015cited by this paper
• Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

  2015cited by this paper
• Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype

  2015cited by this paper
• Breast cancer intrinsic subtype classification, clinical use and future trends.

  2015influential reference
• Mitochondria as biosynthetic factories for cancer proliferation

  2015cited by this paper
• Progress in adjuvant chemotherapy for breast cancer: an overview

  2015cited by this paper
• MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism

  2015cited by this paper
• Application of Metabolomics in Drug Resistant Breast Cancer Research

  2015cited by this paper
• Metabolic control of signalling pathways and metabolic auto‐regulation

  2015cited by this paper
• Metabolomic profiling of hormone-dependent cancers: a bird's eye view.

  2015cited by this paper
• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2015cited by this paper
• Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP

  2015cited by this paper
• Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer

  2015cited by this paper
• ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer

  2015cited by this paper
• Research into cancer metabolomics: Towards a clinical metamorphosis.

  2015cited by this paper
• Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

  2015cited by this paper
• Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.

  2015cited by this paper
• Inflammatory breast cancer: an overview.

  2015cited by this paper
• A roadmap for interpreting (13)C metabolite labeling patterns from cells.

  2015cited by this paper
• Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy

  2015cited by this paper
• cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions

  2015cited by this paper
• Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance123

  2014cited by this paper
• Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues

  2014cited by this paper
• Serine and glycine metabolism in cancer☆

  2014cited by this paper
• Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells

  2014cited by this paper
• Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.

  2014cited by this paper
• Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells

  2014cited by this paper
• Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells

  2014cited by this paper
• Metabolic characterization of triple negative breast cancer

  2014influential reference
• Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

  2014influential reference
• Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation.

  2014cited by this paper
• Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

  2014cited by this paper
• Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.

  2014cited by this paper
• 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes

  2014cited by this paper
• US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.

  2014influential reference
• Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and

  2014cited by this paper
• Influence of metabolism on epigenetics and disease.

  2013cited by this paper
• Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype

  2013cited by this paper
• Heterogeneity of tumor-induced gene expression changes in the human metabolic network

  2013cited by this paper
• Glutamine and cancer: cell biology, physiology, and clinical opportunities.

  2013cited by this paper
• HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers

  2013cited by this paper
• Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells

  2013cited by this paper
• Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes.

  2013cited by this paper
• Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.

  2013cited by this paper
• Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

  2013influential reference
• Nitric oxide and cancer: a review

  2013cited by this paper
• TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists

  2013cited by this paper
• AKT-Induced Tamoxifen Resistance Is Overturned by RRM2 Inhibition

  2013cited by this paper
• Metabolic phenotypes in triple-negative breast cancer

  2013cited by this paper
• Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.

  2013cited by this paper
• Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.

  2013cited by this paper

• Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study

  2025cites this paper
• Future perspective of clinical usefulness of metabolic and mitochondrial heterogeneity in triple-negative breast cancers

  2025cites this paper
• Metabolomic Effects and Their Relationship with Intracellular/Extracellular Concentrations of Casiopeinas® in Triple-Negative Mesenchymal Breast Cancer

  2025cites this paper
• Reprogramming of amino acid metabolism in breast cancer.

  2025cites this paper
• Metabolomics as a tool for understanding and treating triple-negative breast cancer

  2025cites this paper
• Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment—In Vitro, In Vivo and Clinical Trials Literature Review

  2024cites this paper
• Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling

  2024cites this paper
• Targeting metabolism of breast cancer and its implications in T cell immunotherapy

  2024cites this paper
• The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape

  2023cites this paper
• Therapeutic influence of simvastatin on MCF-7 and MDA-MB-231 breast cancer cells via mitochondrial depletion and improvement in chemosensitivity of cytotoxic drugs

  2023cites this paper
• Intratumoral metabolic heterogeneity of colorectal cancer.

  2023cites this paper
• An omics data analysis method based on feature linear relationship and graph convolutional network

  2023cites this paper
• Omics Technologies Improving Breast Cancer Research and Diagnostics

  2023influential citation
• KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer

  2023cites this paper
• Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature

  2023cites this paper
• Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

  2023cites this paper
• Pinpointing Cancer Sub-Type Specific Metabolic Tasks Facilitates Identification of Anti-cancer Targets

  2022cites this paper
• 3'-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells.

  2022cites this paper
• Phosphorescent Metal Halide Nanoclusters for Tunable Photodynamic Therapy

  2022cites this paper
• The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis.

  2022cites this paper
• Repurposing of Metabolic Drugs and Mitochondrial Modulators as an Emerging Class of Cancer Therapeutics with a Special Focus on Breast Cancer

  2022cites this paper
• Comprehensive analysis of metabolic isozyme targets in cancer.

  2022cites this paper
• Physciosporin suppresses mitochondrial respiration, aerobic glycolysis, and tumorigenesis in breast cancer.

  2021cites this paper
• Electrospinning cellulose acetate/silk fibroin/Au-Ag hybrid composite nanofiber for enhanced biocidal activity against MCF-7 breast cancer cell.

  2021cites this paper
• Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes.

  2021cites this paper
• Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification

  2021cites this paper
• HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation

  2021cites this paper
• Raman spectroscopy of breast cancer

  2020cites this paper
• Hydroxycitric Acid Potentiates the Cytotoxic Effect of Tamoxifen in MCF-7 Breast Cancer Cells through Inhibition of ATP Citrate Lyase.

  2020cites this paper
• Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells

  2020cites this paper
• Targeting Subtype-Specific Metabolic Preferences in Nucleotide Biosynthesis Inhibits Tumor Growth in a Breast Cancer Model

  2020cites this paper
• Metabolic reprogramming in triple-negative breast cancer

  2020cites this paper
• Imaging breast cancer using hyperpolarized carbon-13 MRI

  2020cites this paper
• HDAC6 Inhibitors Sensitize Claudin-high Breast Cancer Cells to Cysteine Depletion via Activation of PKCγ Signaling

  2020cites this paper
• UDP-glucose 6-dehydrogenase knockout impairs migration and decreases in vivo metastatic ability of breast cancer cells.

  2020cites this paper
• RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cells

  2020cites this paper
• Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer

  2020cites this paper
• Metabolic regulation of prostate cancer heterogeneity and plasticity.

  2020cites this paper
• DJ-1 Proteoforms in Breast Cancer Cells: The Escape of Metabolic Epigenetic Misregulation

  2020cites this paper
• A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer

  2020cites this paper
• Three dimensional engineered models to study hypoxia biology in breast cancer.

  2020cites this paper
• UDP-Glucose 6-Dehydrogenase Knockout Impairs Migration and Decreases in vivo Metastatic Ability of Breast Cancer Cells

  2020cites this paper
• Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored

  2019cites this paper
• ESTABLISHMENT AND CHARACTERIZATION OF ERASTIN-RESISTANT TRIPLE NEGATIVE BREAST CANCER CELL MODELS

  2019influential citation
• Patofiziološko značenje metaboličkih promjena u solidnim tumorima

  2019influential citation
• Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity

  2019cites this paper
• Precision Medicine

  2019cites this paper
• Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes

  2019cites this paper
• Metabolomics: a systems approach in studying of cancer biology

  2019cites this paper
• FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells.

  2018cites this paper
• Alteration in lipid composition differentiates breast cancer tissues: a 1H HRMAS NMR metabolomic study

  2018cites this paper
• Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.

  2018cites this paper
• The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?

  2018cites this paper
• NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.

  2018cites this paper
• Metabolic reprogramming in type 2 diabetes and the development of breast cancer.

  2018cites this paper